Airmid   Phone: (856) 905-4327
info@airmid.com
 
Target Portfolio
1. Unmet Needs
2. AIRMID Novel Therapeutic Approach
3. AIRMID's Therapeutic Candidates
4. Excellent Safety Profiles
5. Proof-of-concept data
 
 
October 2016
October 2016 Press Release on KPI Therapeutics Presenting Positive Data at Skin Disease Conference
June 2016
June 2016 Press Release About Promising Results of Dalazatide in Lupus Study
June 2016 Fact Sheet: What Is Lupus?
January 2016
January 2016 Press Release on KPI Biotech Showcase
January 2016 Board Member George Miljanich passes
December 2015
December 2015 AIRMID Makes Board Changes
November 2015
November 2015 New Lupus Treatment Being Tested for Younger Patients

more...